Table 1.
0 hr | 3 hr 6 hr 24 hr | |||
---|---|---|---|---|
Total cells × 109/liter | ||||
1 ng/kg | 6.8 ±0.7 | 11.4±0.7 | 10.9 ±1.0 | 6.8 ±0.9 |
0.5 ng/kg | 6.0 ±0.4 | 11.5±0.7 | 10.9 ±1.0 | 6.8 ±0.9 |
0.1 ng/kg | 6.0 ±0.9 | 7.3 ±0.9 | 8.4 ±0.6 | 6.2 ±0.8 |
Placebo | 6.9 ±0.8 | 8.3 ±0.4 | 8.0 ±0.5 | 7.5 ±1.1 |
Neutrophils, % | ||||
1 ng/kg | 55.9±4.7 | 92.7±1.2 | 86.8±1.9 | 57.6±4.3 |
0.5 ng/kg | 59.2±5.3 | 87.0±2.6 | 82.9±4.5 | 56.2±1.7 |
0.1 ng/kg | 58.9±7.4 | 76.0±4.7 | 73.3±2.2 | 61.5±5.5 |
Placebo | 62.5±2.5 | 70.5±6.3 | 67.7±4.6 | 60.3±25.5 |
Monocytes, % | ||||
1 ng/kg | 7.9±1.2 | 2.3±0.9 | 5.1±0.4 | 8.4±0.9 |
0.5 ng/kg | 8.0±0.7 | 3.8±1.4 | 6.9±1.3 | 9.4±2.0 |
0.1 ng/kg | 7.2±1.1 | 6.7±0.5 | 5.4±1.2 | 7.7±1.5 |
Placebo | 7.0±0.9 | 5.6 ±0.9 | 6.1±0.8 | 7.2 ±1.0 |
Lymphocytes, % | ||||
1 ng/kg | 26.4±12.3 | 9.5±3.7 | 5.3±1.7 | 29.4±3.2 |
0.5 ng/kg | 30.4±5.8 | 7.7±2.1 | 9.6±3.1 | 31.6±3.7 |
0.1 ng/kg | 31.2±6.4 | 16.2±4.2 | 19.2±2.7 | 28.4±4.2 |
Placebo | 27.0±1.7 | 21.2±4.6 | 23.1±3.5 | 29.1±5.1 |
Blood samples were obtained at baseline (time 0) and at 3, 6 and 24 hours from subjects after challenge with endotoxin at 1 ng/kg, 0.5 ng/kg or 0.1 ng/kg (n=5 per group). Control subjects (placebo) were administered saline (n=4). Total leukocyte and differential blood cell counts were determined by the clinical laboratory at the university hospital. Two-way repeated-measures analyses of variance were performed relative to placebo group. Changes in total leukocyte count were significant at p≤0.0002 for subjects challenged with endotoxin at 1 ng/kg or 0.5 ng/kg. For both neutrophils and lymphocytes the effects were at significant at p≤0.02 for subjects challenged with endotoxin at1 ng/kg or 0.5 ng/kg. The changes in monocyte counts were not significant for either the 1 ng/kg or 0.5 ng/kg doses. The changes in total leukocyte and differential cell counts were not significant for subjects challenged with endotoxin at 0.1 ng/kg.